Implify successfully closes Series A financing round

Fresh capital for Implify: Series A investment accelerates expansion of warehouse automation solution "Implify Connect" in the medical sector

Frankfurt / Berlin / Hamburg, January 23, 2024 - The Frankfurt-based startup Implify has closed a Series A financing round with a seven-figure investment. Both the existing investor bmh and the venture capital investors seed + speed and Hanse Ventures are participating in the financing. The exact amount of the Series A financing was not officially announced.

Implify was founded in 2020 by Steffen Weinlich, Marc-Philipp Kern and Florian Schnorr. The company focuses on a technology platform in the dental sector that simplifies the ordering process for dental implants and other materials for implant surgery. Around 2,000 dental practices and dental laboratories in the DACH region currently use the solution.

New software solution

The newly developed software solution "Implify Connect" aims to optimize warehouse automation. The storage area is monitored using a combination of hardware and software components. Every withdrawal from the warehouse is automatically recorded and reported to the supplier. This eliminates manual reordering and enables automatic replenishment of the warehouse.

Our modular 'Implify Connect' solution provides a quick and cost-effective remedy, a win-win situation for everyone involved.

Marc-Philipp Kern, Founder and Managing Director of Implify

The solution addresses challenges in the supply chain and administrative processes on the practice and manufacturer side in the dental market. It is designed to minimize manual withdrawal documentation, goods availability checks and waste of resources. High advance payments and capital commitments for manufacturers should also be eliminated. Following successful pilot projects for consignment warehouses of international manufacturers, Implify plans to use the financing to expand the solution to other dental practices, dental laboratories and other areas of the medical sector.

The main purpose of the current financing round is to drive forward the new 'Connect' business segment.

Lena Lang, Investment Manager bmh

Marc-Philipp Kern, founder and CEO of Implify, emphasizes the need for automated solutions along the entire supply chain in the medical market. Daniel Steffen, Senior Investment Manager at seed + speed, emphasizes the increased need to make routines in the dental market more efficient with digital solutions. Sebastian Schulz, Managing Director of Hanse Ventures, emphasizes the adaptability and easy setup of the Implify solution to the reality of dental practices.